140.30USD-19.54%Mkt Cap: 69.62B $P/E: —Today
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal in…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap69.62B $
Enterprise Value49.38B $
Revenue (TTM)2.23B $
Gross Profit1.05B $
Net Income (TTM)-2.82B $
Revenue/Share5.662 USD
Last Price140.30 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees4.7K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS60770K1079
Valuation
P/E (Trailing)—
P/E (Forward)-29.09
PEG—
EV/EBITDA-22.49
EV/Revenue22.16
P/S23.89
P/B7.87
EPS (TTM)-6.11
EPS (Forward)-4.58
52W Range
22.2876% of range176.66
52W High176.66 USD
52W Low22.28 USD
Profitability
Gross Margin54.84%
Oper. Margin-557.93%
EBITDA Margin-98.52%
Profit Margin-146.83%
ROE-32.62%
ROA-22.87%
Growth
Revenue Growth2.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.87B $
CapEx (TTM)202.00M $
FCF Margin13.43%
FCF Yield0.43%
Net Debt-3.85B $
Net Debt/EBITDA1.75
Balance Sheet
Debt/Equity0.15
Current Ratio2.29
Quick Ratio2.07
Book Value/Sh16.95 USD
Cash/Share12.87 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.8 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)89.33 USD
Upside (mean)-36.3%
Target Range25.00 USD – 170.00 USD
$25.00-36.3% to mean$170.00
# Analysts18
Ownership
Shares Out.399.24M
Float372.27M
Insiders7.32%
Institutions80.46%
Short Interest
Short Ratio7.2d
Short % Float15.23%
Short % Out.12.47%
Shares Short49.77M
Short (prev mo.)53.19M
Technical
SMA 5065.62 (+113.8%)
SMA 20048.13 (+191.5%)
Beta0.90
S&P 52W Chg18.16%
Avg Vol (30d)11.29M
Avg Vol (10d)34.57M
Technical Indicators
RSI (14)92.8
MACD9.5576
MACD Signal1.5602
MACD Hist.+7.9974
BB Upper116.39 USD
BB Middle63.95 USD
BB Lower11.52 USD
BB Width163.97%
ATR (14)11.50 USD
Vol Ratio (20d)36.08x